Info
Schedule 13D

Biotechnology Value Fund L P - Significant Ownership

Signature - Title: /s/ Mark N. Lampert - Mark N. Lampert, Authorized Signatory
Location: San Francisco, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Biotechnology Value Fund L P.

Significant Ownership of Biotechnology Value Fund L P

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
XOMA	XOMA Royalty Corp	Common Stock, $0.0075 par value	21.6%	$63.7M	-$9.66M	2.59M	-13.2%	BVF GP HOLDINGS LLC	May 16, 2025
EPIX	ESSA Pharma Inc.	Common Shares	19.7%	$15.7M		8.75M		BVF PARTNERS L P/IL	Apr 9, 2025
GHRS	GH Research PLC	Ordinary Shares, nominal value $0.025 per share	14.2%	$84.1M		8.83M		BVF PARTNERS L P/IL	Mar 31, 2025
VSTM	Verastem, Inc.	Common Stock, $0.0001 par value per share	9.99%	$32.9M		4.71M		BVF PARTNERS L P/IL	Dec 31, 2024
CDTX	Cidara Therapeutics, Inc.	Common Stock, par value $0.0001 per share	9.99%	$26.9M	$3.41M	1.25M	+14.5%	BVF PARTNERS L P/IL	Mar 31, 2025
FDMT	4D Molecular Therapeutics, Inc.	Common Stock, par value $0.0001 per share	9.99%	$15.1M	-$655K	4.63M	-4.17%	BVF PARTNERS L P/IL	Mar 31, 2025
VIGL	Vigil Neuroscience, Inc.	Common Stock, par value $0.0001 per share	9.99%	$8.47M		4.73M		BVF PARTNERS L P/IL	Mar 31, 2025
TCRX	TScan Therapeutics, Inc.	Voting Common Stock, $0.0001 par value per share	9.99%	$8.42M		5.26M		BVF PARTNERS L P/IL	Mar 31, 2025
AVTX	Avalo Therapeutics, Inc.	Common Stock, $0.001 par value per share	9.99%	$5.19M		1.04M		BVF PARTNERS L P/IL	Dec 31, 2024
FBRX	Forte Biosciences, Inc.	Common Stock, $0.001 par value	9.99%	$4.75M		644K		BVF PARTNERS L P/IL	Dec 31, 2024
VTGN	Vistagen Therapeutics, Inc.	Common Stock, par value $0.001 per share	9.97%	$7.22M		3.08M		BVF PARTNERS L P/IL	Dec 31, 2024
SEPN	Septerna, Inc.	Common Stock, $0.001 par value per share	9.9%	$30.8M		4.4M		BVF PARTNERS L P/IL	Mar 31, 2025
GLUE	Monte Rosa Therapeutics, Inc.	Common Stock, $0.0001 par value per share	9.2%	$29.5M	$6.61M	5.66M	+28.8%	BVF PARTNERS L P/IL	Mar 31, 2025
RAPT	RAPT Therapeutics, Inc.	Common Stock, $0.0001 par value per share	8.7%	$10.2M		11.8M		BVF PARTNERS L P/IL	Dec 27, 2024
IKNA	Ikena Oncology, Inc.	Common Stock, par value $0.001 per share	8.3%	$4.25M		4.01M		BVF PARTNERS L P/IL	Dec 31, 2024
ITOS	iTeos Therapeutics, Inc.	Common Stock, $0.001 par value per share	8.1%	$22.6M		3.08M		BVF PARTNERS L P/IL	Mar 31, 2025
TYRA	Tyra Biosciences, Inc.	Common Stock, $0.0001 par value per share	7.8%	$40.5M		3.94M		BVF PARTNERS L P/IL	Dec 31, 2024
KURA	Kura Oncology, Inc.	Common Stock, par value $0.0001 per share	7.5%	$38.5M	$16.3M	5.91M	+73.5%	BVF PARTNERS L P/IL	Jan 27, 2025
ELEV	Elevation Oncology, Inc.	Common Stock, par value $0.0001 per share	7%	$1.64M		4.44M		BVF PARTNERS L P/IL	Mar 31, 2025
IVA	Inventiva S.A.	Ordinary Shares, nominal value (euro)0.01 per share	6.1%	$32M		8.55M	0%	BVF PARTNERS L P/IL	May 7, 2025
PTGX	Protagonist Therapeutics, Inc	Common Stock, $0.00001 par value per share	5.2%	$147M		3.21M		BVF PARTNERS L P/IL	Jun 9, 2025
ETNB	89bio, Inc.	Common Stock, par value $0.001 per share	3.6%	$29.9M		4.33M		BVF PARTNERS L P/IL	Dec 31, 2024
ENGN	enGene Holdings Inc.	Common Shares, no par value per share	1.8%	$3.78M	-$8.42M	945K	-69%	BVF PARTNERS L P/IL	Jan 27, 2025
THRD	Third Harmonic Bio, Inc.	Common Stock, par value $0.0001 per share	0%	$0		0		BIOTECHNOLOGY VALUE FUND L P	Apr 14, 2025
ALLK	Allakos Inc.	Common Stock, par value $0.001	0%	$0		0		BIOTECHNOLOGY VALUE FUND L P	May 15, 2025

Previous1Next

Showing 1 to 25 of 25 entries

Schedules 13D/G Reported by Biotechnology Value Fund L P:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
Loading...

PreviousNext

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.